Fragoso-Saavedra, Sergio
Iruegas-Nunez, David A.
Quintero-Villegas, Alejandro
García-González, H. Benjamín
Nuñez, Isaac
Carbajal-Morelos, Sergio L.
Audelo-Cruz, Belem M.
Arias-Martínez, Sarahi
Caro-Vega, Yanink
Calva, Juan José
Luqueño-Martínez, Verónica
González-Duarte, Alejandra
Crabtree-Ramírez, Brenda
Crispín, José C.
Sierra-Madero, Juan
Belaunzarán-Zamudio, Pablo F.
Valdés-Ferrer, Sergio I. http://orcid.org/0000-0002-4863-6484
Funding for this research was provided by:
Consejo Nacional de Ciencia y Tecnología (311783, FOSISS-289788)
Article History
Received: 19 August 2020
Accepted: 7 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: This study is being carried out in accordance with the recommendations of the institutional Ethics in Human Research Committees. All participants will have given written informed consent to one of the study investigators in accordance with the Declaration of Helsinki. The protocol was approved by the Ethics in Human Research Committees of <i>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</i> (INCMNSZ)<i>,</i> and <i>Instituto Nacional de Cardiología Ignacio Chávez</i>, both in Mexico City, Mexico<i>;</i> and <i>Comisión Federal para la Protección contra Riesgos Sanitarios</i> (COFEPRIS), the Federal Mexican pharmacological regulatory commission.
: Not applicable.
: Pablo F Belaunzarán-Zamudio is an Associated Editor for the HIV and co-infections section of BMC Infectious Diseases.